Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Short Communication
Authors: Wang, Heng Li
Affiliations: Clinical Laboratory, The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai, Guangdong 519000, China | E-mail: chentaitaiwang@sohu.com
Correspondence: [*] Corresponding author: Clinical Laboratory, The Fifth Affiliated Hospital Sun Yat-Sen University, Zhuhai, Guangdong 519000, China. E-mail: chentaitaiwang@sohu.com.
Abstract: BACKGROUND: The use of transcutaneous electrical stimulation for neuromodulation is an important treatment strategy for functional nerve diseases. It can not only reduce patient pain and prevent the development of drug-resistant disease, but is also more effective than alternative treatment methods. OBJECTIVE: Ag/AgCl electrodes are commonly used for transcutaneous stimulation. However, the silver ions can dissolve in tissue during electrical stimulation, which can lead to heavy metal poisoning and other issues. This study analyzed the amount of residual silver ions found in tissue after electrical stimulation. METHODS: Saline solution and animal skin were chosen as experimental analogs for human tissue and the amount of residual silver ions were analyzed via ultraviolet spectrophotometer. RESULTS: After a volume-to-quantity conversion, we found that after using a pair of electrodes for three hours, the concentrations of silver ions dissolved in the saline solution and the skin were less than 0.1 ppb and 0.5 ppb, respectively, due to its low solubility. CONCLUSIONS: By analyzing the ion dissolution concentration, we found that the residual silver ion concentration in vivo was less than 0.1 ppb, which is within the safe range for humans. Therefore, we believe it is safe to use Ag/AgCl electrodes for transcutaneous electrical stimulation.
Keywords: Transcutaneous electrical stimulation, neuromodulation, saline experiment, pigskin experiment, Ag ion dissolution concentration
DOI: 10.3233/THC-202192
Journal: Technology and Health Care, vol. 28, no. 4, pp. 453-459, 2020
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl